Loading…
Synaptiflora is a microbiome intelligence platform that profiles bacteria, fungi, viruses, and phages to link microbes and genes to biochemical pathways and drug interactions. It aims to improve drug development by raising efficacy rates from 40% to 60-80% and cutting clinical trial timelines by half.
AI named Synaptiflora in February 2026.